Christen, M.; Kaderli, D.; Ratknic, M.; de Angelis, A.D.; Aebi, P.S.; Porret, N.; Tchinda, J.; Baran, N.; Rim, W.; Tanner, P.J.;
et al. Real-World Retrospective Report on the Efficacy, Tolerability, and Molecular Responses to Ropeginterferon-α2b in Patients with Myeloproliferative Neoplasms. J. Clin. Med. 2026, 15, 128.
https://doi.org/10.3390/jcm15010128
AMA Style
Christen M, Kaderli D, Ratknic M, de Angelis AD, Aebi PS, Porret N, Tchinda J, Baran N, Rim W, Tanner PJ,
et al. Real-World Retrospective Report on the Efficacy, Tolerability, and Molecular Responses to Ropeginterferon-α2b in Patients with Myeloproliferative Neoplasms. Journal of Clinical Medicine. 2026; 15(1):128.
https://doi.org/10.3390/jcm15010128
Chicago/Turabian Style
Christen, Matthias, Domenic Kaderli, Milos Ratknic, Adrián Dante de Angelis, Philipp Stefan Aebi, Naomi Porret, Joëlle Tchinda, Natalia Baran, Wuddri Rim, Pascale Julia Tanner,
and et al. 2026. "Real-World Retrospective Report on the Efficacy, Tolerability, and Molecular Responses to Ropeginterferon-α2b in Patients with Myeloproliferative Neoplasms" Journal of Clinical Medicine 15, no. 1: 128.
https://doi.org/10.3390/jcm15010128
APA Style
Christen, M., Kaderli, D., Ratknic, M., de Angelis, A. D., Aebi, P. S., Porret, N., Tchinda, J., Baran, N., Rim, W., Tanner, P. J., Mathes, S., Angelillo-Scherrer, A., Rovó, A., & Meyer, S. C.
(2026). Real-World Retrospective Report on the Efficacy, Tolerability, and Molecular Responses to Ropeginterferon-α2b in Patients with Myeloproliferative Neoplasms. Journal of Clinical Medicine, 15(1), 128.
https://doi.org/10.3390/jcm15010128
